Form 4: Edgewise Therapeutics CFO R. Michael Carruthers Reports Stock Transactions
SEC Form 4 Filing
R. Michael Carruthers, CFO of Edgewise Therapeutics, reports the acquisition and disposal of company stock related to restricted stock units and tax obligations.
Summary
- R. Michael Carruthers, the Chief Financial Officer of Edgewise Therapeutics, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On May 1, 2025, Carruthers acquired 5,209 shares of common stock through the vesting of Restricted Stock Units (RSUs) at a price of $0.00.
- On May 2, 2025, Carruthers sold 1,314 shares of common stock at an average price of $16.4542 to cover statutory tax withholding obligations.
- Following these transactions, Carruthers beneficially owns 81,014 shares of Edgewise Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document reflects routine stock transactions by a company executive, primarily for tax obligations related to vested stock. It doesn't indicate any significant positive or negative developments for the company.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations. This filing indicates routine transactions related to executive compensation and tax obligations.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 11/15/2024 | 215 shares purchased pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. |
| 05/01/2025 | Acquisition of 5,209 shares of common stock through RSU vesting. |
| 05/02/2025 | Sale of 1,314 shares to cover statutory tax withholding obligations. |
| 05/01/2032 | Expiration date of Restricted Stock Units |
| 05/07/2025 | Date of Form 4 signature. |
Keywords
Form 4, Beneficial Ownership, R. Michael Carruthers, Edgewise Therapeutics, EWTX, CFO, Stock Transactions, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.